Center for Scientific Review; Notice of Closed Meetings, 30998-30999 [2023-10263]
Download as PDF
<![CDATA[
30998
Federal Register / Vol. 88, No. 93 / Monday, May 15, 2023 / Notices
National Institutes of Health
National Toxicology Program Board of
Scientific Counselors; Announcement
of Meeting
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
This notice announces
continuation of the May 4, 2023,
meeting of the National Toxicology
Program (NTP) Board of Scientific
Counselors (BSC) on May 16, 2023. The
BSC is a federally chartered, external
advisory group composed of scientists
from the public and private sectors.
During a public meeting on May 4, the
BSC considered a report from its
Working Group containing proposed
recommendations on whether NTP
authors sufficiently addressed internal
and external scientific comments on
NTP’s systematic review to evaluate the
neurobehavioral health effects from
exposure to fluoride during
development, as set forth in NTP’s Draft
State of the Science Monograph and
Draft Meta-Analysis Manuscript. After
deliberation and discussion, the BSC
voted to accept the Working Group’s
report in full, with the exception of one
paragraph on page 323 related to an IQ
statistic that the BSC asked the Working
Group to verify or correct. The Working
Group has reexamined the text, and the
BSC will discuss and deliberate the
Working Group’s updated input at the
meeting on May 16. This is a virtual
meeting and open to the public. This
notice is being published less than 15
days prior to the meeting due to
scheduling difficulties.
DATES:
Meeting: Scheduled for May 16, 2023,
3:00–3:30 p.m. Eastern Daylight Time
(EDT). Ending time is approximate;
meeting may end earlier or run later.
ADDRESSES:
Meeting web page: The preliminary
agenda and other meeting materials will
be available at https://ntp.niehs.nih.gov/
go/165 by 5 p.m. on May 12, 2023.
Virtual Meeting: A link to the URL for
viewing the virtual meeting will be
provided on the meeting web page by
noon the day before the meeting.
FOR FURTHER INFORMATION CONTACT: Dr.
Milene Brownlow, Designated Federal
Officer for the BSC, Office of Policy,
Review, and Outreach, Division of
Translational Toxicology, NIEHS.
Phone: 984–287–3364, Email:
milene.brownlow@nih.gov.
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
19:07 May 12, 2023
Jkt 259001
The NTP
conducted a systematic review to
evaluate the neurobehavioral health
effects from exposure to fluoride during
development and prepared a Draft State
of the Science Monograph and a Draft
Meta-Analysis Manuscript. Both draft
documents were reviewed internally by
various Department of Health and
Human Services (HHS) entities and,
additionally, the Draft State of the
Science Monograph underwent external
peer review by five scientific experts.
Subsequently, the NTP Director decided
to seek additional review of these
documents from the NTP BSC. In 2022,
the NTP Director and the NTP BSC
Chair jointly made the decision to
convene an independent working group
of subject-matter experts to assist the
BSC in reviewing the input on the two
documents along with NTP authors’
responses to the comments. The BSC
Working Group’s report with its
recommendations on whether the
authors sufficiently addressed internal
and external scientific comments was
deliberated at the BSC at a meeting on
May 4, 2023. The BSC voted to accept
the Working Group’s report in full, with
the exception of one paragraph on page
323 related to an IQ statistic that the
BSC asked the Working Group to verify
or correct. The meeting on May 16,
2023, is a continuation of the May 4
meeting where the BSC will take action
on the BSC Working Group’s updated
input. This is the only agenda topic for
this meeting.
The preliminary agenda, the Working
Group Report as approved by the BSC
on May 4, 2023, the Working Group’s
updated text about the IQ statistic, the
roster of BSC members, and any
additional information, when available,
will be posted on the BSC meeting web
page (https://ntp.niehs.nih.gov/go/165),
and minutes will be available on the
BSC meeting web page within 90
calendar days of the meeting.
Meeting Attendance Registration: The
meeting is open to the public.
Registration is not required to view the
virtual meeting; a link to the webcast for
the virtual meeting will be provided on
the BSC meeting web page (https://
ntp.niehs.nih.gov/go/165) by noon the
day before the meeting. TTY users
should contact the Federal TTY Relay
Service at 800–877–8339. Requests
should be made at least five business
days in advance of the event.
Meeting Materials: The preliminary
meeting agenda will be available on the
meeting web page (https://ntp.niehs.
nih.gov/go/165) by 5 p.m. on May 12,
2023. Individuals are encouraged to
access the meeting web page
periodically to stay abreast of the most
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
current information regarding the
meeting.
Background Information on the BSC:
The BSC is a technical advisory body
comprised of scientists from the public
and private sectors that provides
primary scientific oversight to the NTP.
Specifically, the BSC advises the NTP
on matters of scientific program content,
both present and future, and conducts
periodic review of the program for the
purpose of determining and advising on
the scientific merit of its activities and
their overall scientific quality. Its
members are selected from recognized
authorities knowledgeable in fields such
as toxicology, pharmacology, pathology,
epidemiology, risk assessment,
carcinogenesis, mutagenesis, cellular
biology, computational toxicology,
neurotoxicology, genetic toxicology,
reproductive toxicology or teratology,
and biostatistics. Members serve
overlapping terms of up to four years.
The BSC usually meets periodically.
The authority for the BSC is provided by
42 U.S.C. 217a, section 222 of the Public
Health Service Act (PHS), as amended.
The BSC is governed by the
provisions of the Federal Advisory
Committee Act, as amended (5 U.S.C.
ch. 10).
Dated: May 9, 2023.
Richard P. Woychik,
Director, National Institute of Environmental
Health Sciences and National Toxicology
Program, National Institutes of Health.
[FR Doc. 2023–10230 Filed 5–12–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Special
E:\FR\FM\15MYN1.SGM
15MYN1
ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 88, No. 93 / Monday, May 15, 2023 / Notices
Topics: Noninvasive Neuromodulation and
Neuroimaging Technologies.
Date: June 9, 2023.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Hybrid Meeting).
Contact Person: Pablo Miguel Blazquez
Gamez, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (301) 435–1042,
pablo.blazquezgamez@nih.gov.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group; Child Psychopathology and
Developmental Disabilities Study Section.
Date: June 12–13, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Karen Elizabeth Seymour,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1000–E,
Bethesda, MD 20892, (301) 443–9485,
karen.seymour@nih.gov.
Name of Committee: Applied Immunology
and Disease Control Integrated Review
Group; Transmission of Vector-Borne and
Zoonotic Diseases Study Section.
Date: June 12–13, 2023.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Haruhiko Murata, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20892, 301–594–3245,
muratah@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR 20–
103: Collaborative Program Grant for
Multidisciplinary Teams (RM1).
Date: June 12, 2023.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sergei Ruvinov, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4158,
MSC 7806, Bethesda, MD 20892, 301–435–
1180, ruvinser@csr.nih.gov.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group; Neurobiology of
Pain and Itch Study Section.
Date: June 13–14, 2023.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
VerDate Sep<11>2014
19:07 May 12, 2023
Jkt 259001
Contact Person: Anne-Sophie Marie Lucie
Wattiez, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (301) 594–4642, annesophie.wattiez@nih.gov.
Name of Committee: Molecular, Cellular
and Developmental Neuroscience Integrated
Review Group; Neurodifferentiation,
Plasticity, Regeneration and Rhythmicity
Study Section.
Date: June 13–14, 2023.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jacek Topczewski, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1002A1,
Bethesda, MD 20892, (301) 594–7574,
topczewskij2@csr.nih.gov.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group; Genetic
Variation and Evolution Study Section.
Date: June 13–14, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Guoqin Yu, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 435–1276, guoqin.yu@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; AntiInfective Resistance and Targets Study
Section.
Date: June 13–14, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jui Pandhare, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–7735, pandharej2@
csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: May 9, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–10263 Filed 5–12–23; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
30999
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Stem Cell III.
Date: June 20, 2023.
Time: 11:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Aging, Gateway
Building, 7201 Wisconsin Avenue, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Nijaguna Prasad, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, 7201
Wisconsin Avenue, Gateway Bldg., Suite
2W200, Bethesda, MD 20892, (301) 496–
9667, prasadnb@nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: May 9, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–10269 Filed 5–12–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
E:\FR\FM\15MYN1.SGM
15MYN1
]]>Agencies
[Federal Register Volume 88, Number 93 (Monday, May 15, 2023)]
[Notices]
[Pages 30998-30999]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-10263]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Special
[[Page 30999]]
Topics: Noninvasive Neuromodulation and Neuroimaging Technologies.
Date: June 9, 2023.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Hybrid Meeting).
Contact Person: Pablo Miguel Blazquez Gamez, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 435-1042,
[email protected].
Name of Committee: Biobehavioral and Behavioral Processes
Integrated Review Group; Child Psychopathology and Developmental
Disabilities Study Section.
Date: June 12-13, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Karen Elizabeth Seymour, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1000-E, Bethesda, MD 20892, (301)
443-9485, [email protected].
Name of Committee: Applied Immunology and Disease Control
Integrated Review Group; Transmission of Vector-Borne and Zoonotic
Diseases Study Section.
Date: June 12-13, 2023.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Haruhiko Murata, Ph.D., Scientific Review
Officer, Center for Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20892, 301-594-3245, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR 20-103: Collaborative Program Grant for Multidisciplinary
Teams (RM1).
Date: June 12, 2023.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sergei Ruvinov, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4158, MSC 7806, Bethesda, MD
20892, 301-435-1180, [email protected].
Name of Committee: Integrative, Functional and Cognitive
Neuroscience Integrated Review Group; Neurobiology of Pain and Itch
Study Section.
Date: June 13-14, 2023.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Anne-Sophie Marie Lucie Wattiez, Ph.D.,
Scientific Review Officer, Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892,
(301) 594-4642, [email protected].
Name of Committee: Molecular, Cellular and Developmental
Neuroscience Integrated Review Group; Neurodifferentiation,
Plasticity, Regeneration and Rhythmicity Study Section.
Date: June 13-14, 2023.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jacek Topczewski, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1002A1, Bethesda, MD 20892, (301)
594-7574, [email protected].
Name of Committee: Genes, Genomes, and Genetics Integrated
Review Group; Genetic Variation and Evolution Study Section.
Date: June 13-14, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Guoqin Yu, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892, (301) 435-1276,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Anti-Infective Resistance and Targets Study Section.
Date: June 13-14, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jui Pandhare, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892, (301) 594-7735,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: May 9, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-10263 Filed 5-12-23; 8:45 am]
BILLING CODE 4140-01-P
